Histology
Carcinoma of Unknown Primary
CI-CAN-00002109Explore in graph →
4,156 active trials54 approved drugs532 evidence items
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00002109Explore in graph →
Clinical trials
14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,893)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00339131 | ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid | completed | Phase 1 | 24 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 0 | Oct 12, 2011 | clinicaltrials |
| NCT00563147 | A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma | completed | Phase 1 | 28 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 4, 2011 |
| clinicaltrials |
| NCT01387061 | Resection for Multiple Hepatocellular Carcinomas (HCC) | completed | N/A | 87 | University of MilanOTHER | 1 | Sep 20, 2011 | clinicaltrials |
| NCT00267748 | Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC) | completed | Phase 2 | 317 | PfizerINDUSTRY | 1 | Sep 5, 2011 | clinicaltrials |
| NCT00663429 | Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma | completed | Phase 2 | 10 | Callisto PharmaceuticalsINDUSTRY | 1 | Aug 31, 2011 | clinicaltrials |
| NCT00113529 | Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 42 | PfizerINDUSTRY | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00478114 | Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) | completed | Phase 3 | 15 | Mahidol UniversityOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00703365 | Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 45 | Mahidol UniversityOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00073736 | Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 28 | Ligand PharmaceuticalsINDUSTRY | 3 | Aug 12, 2011 | clinicaltrials |
| NCT00324272 | Post-Operative Drainage Following Lymph Node Dissection | completed | Phase 4 | 74 | Oxford University Hospitals NHS TrustOTHER | 0 | Aug 11, 2011 | clinicaltrials |
| NCT00444314 | Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 2 | 82 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00003038 | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00287222 | Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma | completed | Phase 2 | 21 | University of ArkansasOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00882869 | XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 75 | Aegera TherapeuticsINDUSTRY | 1 | Jul 13, 2011 | clinicaltrials |
| NCT00868088 | Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip | completed | Phase 4 | 34 | Tufts Medical CenterOTHER | 1 | Jul 6, 2011 | clinicaltrials |
| NCT00910572 | Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | completed | Phase 2 | 60 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00590343 | Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors(PTK787) | completed | Phase 2 | 23 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00559455 | Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 2 | 38 | SanofiINDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00780663 | Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 2 | 25 | Cylene PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00140075 | Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer | completed | Phase 3 | 606 | PfizerINDUSTRY | 1 | May 26, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT00616135 | Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy(RESTORE-2) | completed | Phase 4 | 71 | Cytori TherapeuticsINDUSTRY | 4 | May 17, 2011 | clinicaltrials |
| NCT01328691 | Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor Thrombus | completed | — | 118 | Seoul National University HospitalOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00437424 | A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction | completed | Phase 1 | 24 | Bristol-Myers SquibbINDUSTRY | 2 | May 4, 2011 | clinicaltrials |
| NCT00317200 | A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer | completed | Phase 2 | 34 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT00403403 | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) | completed | Phase 2 | 102 | Genentech, Inc.INDUSTRY | 0 | Apr 29, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00875381 | Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin | completed | — | 100 | Mayo ClinicOTHER | 0 | Mar 15, 2011 | clinicaltrials |
| NCT00225927 | Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers | completed | N/A | 333 | McMaster UniversityOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00206219 | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) | completed | Phase 3 | 477 | AstraZenecaINDUSTRY | 25 | Jan 27, 2011 | clinicaltrials |
| NCT00502164 | Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer(AZD2171IL/0003) | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00411151 | Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer | completed | Phase 2 | 52 | Johannes Gutenberg University MainzOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT01254838 | Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma | completed | Phase 1 | — | Iwate Medical UniversityOTHER | 0 | Dec 7, 2010 | clinicaltrials |
| NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy(SILIUS) | completed | Phase 1 / Phase 2 | 37 | Kindai UniversityOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT00156286 | Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC | completed | Phase 2 | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 16, 2010 | clinicaltrials |
| NCT00460798 | SUTENT® In The First Line Treatment Of Renal Cell Carcinoma(SUNIKA) | completed | — | 356 | PfizerINDUSTRY | 0 | Nov 16, 2010 | clinicaltrials |
| NCT00509704 | Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma | completed | — | 10 | Radboud University Medical CenterOTHER | 1 | Nov 9, 2010 | clinicaltrials |
| NCT00768937 | Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 22 | Medical University of ViennaOTHER | 1 | Nov 9, 2010 | clinicaltrials |
| NCT01237132 | East-West Hepatocellular Carcinoma Study Group | completed | — | — | University of MilanOTHER | 0 | Nov 9, 2010 | clinicaltrials |
| NCT00478374 | Sorafenib With TACE to Treat Hepatocellular Carcinoma(S-TACE) | completed | Phase 1 | 21 | University of BernOTHER | 1 | Nov 2, 2010 | clinicaltrials |
| NCT00789841 | Gastrointestinal Motility in Patients With Neuroendocrine Tumors | completed | — | 13 | University of AarhusOTHER | 1 | Oct 26, 2010 | clinicaltrials |
| NCT01222936 | LBH Phase II in Small Cell Lung Cancer (SCLC) | completed | Phase 2 | 21 | Southern Europe New Drug OrganizationOTHER | 2 | Oct 18, 2010 | clinicaltrials |
| NCT00077974 | A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. | completed | Phase 2 | 106 | PfizerINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00430261 | Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma | completed | Phase 2 | 20 | Swedish Medical CenterOTHER | 1 | Oct 6, 2010 | clinicaltrials |
| NCT00895674 | Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar | completed | — | 2,840 | BayerINDUSTRY | 18 | Sep 30, 2010 | clinicaltrials |
| NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients(EACH) | completed | Phase 3 | 371 | SanofiINDUSTRY | 4 | Sep 20, 2010 | clinicaltrials |
| NCT00432315 | Docetaxel in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 80 | SanofiINDUSTRY | 1 | Sep 14, 2010 | clinicaltrials |
| NCT00490685 | Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 142 | Istituto Clinico HumanitasOTHER | 1 | Sep 2, 2010 | clinicaltrials |
| NCT00397293 | Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 24, 2010 | clinicaltrials |
| NCT01176552 | Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer | completed | Phase 2 | 35 | Kidney Cancer Research BureauOTHER | 1 | Aug 24, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Oct 12, 2011source: clinicaltrials